See more : Lytus Technologies Holdings PTV. Ltd. (LYTWW) Income Statement Analysis – Financial Results
Complete financial analysis of West Pharmaceutical Services, Inc. (WST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of West Pharmaceutical Services, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Takasago Tekko K.K. (5458.T) Income Statement Analysis – Financial Results
- Centum Electronics Limited (CENTUM.BO) Income Statement Analysis – Financial Results
- Royal India Corporation Limited (ROYALIND.BO) Income Statement Analysis – Financial Results
- BioLASCO Taiwan Co., Ltd. (6662.TWO) Income Statement Analysis – Financial Results
- GAMERICA Holdings and Acquisitions Corp. (VOIS) Income Statement Analysis – Financial Results
West Pharmaceutical Services, Inc. (WST)
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.95B | 2.89B | 2.83B | 2.15B | 1.84B | 1.72B | 1.60B | 1.51B | 1.40B | 1.42B | 1.37B | 1.27B | 1.19B | 1.10B | 1.06B | 1.05B | 1.02B | 913.30M | 699.70M | 541.60M | 490.70M | 419.70M | 396.90M | 430.10M | 469.10M | 449.70M | 452.50M | 458.80M | 412.90M | 365.10M | 348.70M | 338.20M | 329.60M | 323.20M | 308.70M | 288.20M | 253.30M | 235.60M | 190.10M |
| Cost of Revenue | 1.82B | 1.75B | 1.66B | 1.38B | 1.23B | 1.17B | 1.09B | 1.01B | 944.00M | 973.60M | 933.70M | 878.70M | 853.00M | 786.60M | 752.10M | 748.50M | 728.30M | 651.50M | 507.10M | 385.70M | 334.90M | 302.10M | 280.80M | 289.70M | 289.10M | 282.20M | 288.50M | 302.00M | 265.10M | 225.90M | 222.10M | 217.80M | 221.40M | 221.50M | 206.70M | 197.40M | 174.40M | 160.20M | 128.00M |
| Gross Profit | 1.13B | 1.14B | 1.18B | 767.80M | 605.70M | 545.40M | 512.60M | 501.10M | 455.80M | 447.80M | 434.70M | 387.70M | 339.30M | 318.10M | 303.60M | 302.60M | 291.80M | 261.80M | 192.60M | 155.90M | 155.80M | 117.60M | 116.10M | 140.40M | 180.00M | 167.50M | 164.00M | 156.80M | 147.80M | 139.20M | 126.60M | 120.40M | 108.20M | 101.70M | 102.00M | 90.80M | 78.90M | 75.40M | 62.10M |
| Gross Profit Ratio | 38.28% | 39.36% | 41.52% | 35.76% | 32.92% | 31.76% | 32.06% | 33.21% | 32.56% | 31.50% | 31.77% | 30.61% | 28.46% | 28.80% | 28.76% | 28.79% | 28.61% | 28.67% | 27.53% | 28.79% | 31.75% | 28.02% | 29.25% | 32.64% | 38.37% | 37.25% | 36.24% | 34.18% | 35.80% | 38.13% | 36.31% | 35.60% | 32.83% | 31.47% | 33.04% | 31.51% | 31.15% | 32.00% | 32.67% |
| Research & Development | 68.40M | 58.50M | 52.80M | 46.90M | 38.90M | 40.30M | 39.10M | 36.80M | 34.10M | 37.30M | 37.90M | 33.20M | 29.10M | 23.90M | 19.90M | 18.70M | 16.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 262.90M | 242.60M | 239.80M | 233.00M | 228.70M | 234.90M | 218.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 353.40M | 316.90M | 362.80M | 302.00M | 272.70M | 262.90M | 242.60M | 239.80M | 233.00M | 228.70M | 234.90M | 218.10M | 191.10M | 187.70M | 177.70M | 159.30M | 152.50M | 155.90M | 120.30M | 105.20M | 111.00M | 82.60M | 73.40M | 67.70M | 77.90M | 70.50M | 70.20M | 72.80M | 69.90M | 69.00M | 63.50M | 57.10M | 85.00M | 57.80M | 45.60M | 41.50M | 32.20M | 29.90M | 26.60M |
| Other Expenses | 31.50M | 26.80M | 7.90M | 12.00M | 2.40M | 4.80M | -2.00M | -27.70M | -60.10M | 200.00K | 500.00K | 5.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 454.00M | 402.20M | 423.50M | 360.90M | 311.60M | 303.20M | 281.70M | 276.60M | 267.10M | 266.00M | 272.80M | 251.30M | 221.70M | 213.30M | 197.60M | 191.90M | 168.60M | 160.80M | 121.70M | 106.70M | 94.30M | 81.00M | 71.90M | 104.70M | 113.60M | 102.80M | 102.10M | 103.50M | 99.50M | 92.10M | 85.50M | 80.70M | 109.50M | 80.50M | 65.90M | 60.40M | 49.00M | 44.60M | 38.60M |
| Cost & Expenses | 2.27B | 2.15B | 2.08B | 1.74B | 1.55B | 1.48B | 1.37B | 1.28B | 1.21B | 1.24B | 1.21B | 1.13B | 1.07B | 999.90M | 949.70M | 940.40M | 896.90M | 812.30M | 628.80M | 492.40M | 429.20M | 383.10M | 352.70M | 394.40M | 402.70M | 385.00M | 390.60M | 405.50M | 364.60M | 318.00M | 307.60M | 298.50M | 330.90M | 302.00M | 272.60M | 257.80M | 223.40M | 204.80M | 166.60M |
| Interest Income | 28.00M | 5.10M | 1.00M | 1.40M | 3.80M | 2.10M | 1.30M | 1.10M | 1.60M | 3.50M | 1.90M | 1.80M | 1.30M | 600.00K | 800.00K | 1.40M | 6.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.00M | 7.90M | 7.20M | 6.80M | 4.70M | 6.30M | 6.50M | 7.00M | 12.50M | 13.00M | 15.10M | 14.90M | 18.20M | 16.80M | 14.40M | 16.00M | 14.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 137.30M | 120.60M | 122.30M | 109.10M | 103.40M | 104.40M | 96.70M | 90.70M | 89.90M | 90.00M | 85.20M | 76.90M | 75.70M | 73.20M | 68.10M | 60.60M | 56.60M | 52.70M | 47.40M | 33.20M | 33.00M | 33.00M | 32.00M | 37.00M | 35.70M | 32.30M | 31.90M | 30.70M | 29.60M | 23.10M | 22.00M | 23.60M | 24.50M | 22.70M | 20.30M | 18.90M | 16.80M | 14.70M | 12.00M |
| EBITDA | 844.10M | 887.90M | 895.20M | 531.70M | 399.40M | 355.30M | 335.90M | 319.60M | 220.00M | 273.30M | 249.00M | 200.00M | 183.40M | 161.30M | 166.40M | 186.10M | 157.50M | 149.90M | 122.90M | 94.50M | 84.80M | 82.80M | 74.70M | 75.90M | 102.10M | 97.00M | 93.80M | 84.00M | 77.90M | 70.20M | 63.10M | 63.30M | 23.20M | 43.90M | 56.40M | 49.30M | 46.70M | 45.50M | 35.50M |
| EBITDA Ratio | 28.62% | 29.60% | 31.02% | 24.09% | 21.73% | 14.38% | 14.31% | 13.04% | 9.19% | 12.80% | 11.87% | 11.20% | 10.53% | 10.76% | 9.95% | 10.65% | 20.40% | 18.01% | 19.39% | 15.68% | 17.28% | 18.56% | 19.55% | 21.39% | 21.49% | 28.13% | 20.38% | 22.47% | 18.29% | 19.56% | 17.95% | 18.72% | 6.71% | 14.91% | 16.94% | 16.20% | 19.31% | 18.34% | 16.99% |
| Operating Income | 676.00M | 734.00M | 752.30M | 406.90M | 296.60M | 240.30M | 228.90M | 196.80M | 128.60M | 182.00M | 162.40M | 135.10M | 109.60M | 90.70M | 97.50M | 124.10M | 94.90M | 101.00M | 72.20M | 48.20M | 54.50M | 26.70M | 41.30M | 35.70M | 66.40M | 64.70M | 61.90M | 53.30M | 48.30M | 47.10M | 41.10M | 39.70M | -1.30M | 21.20M | 36.10M | 30.40M | 29.90M | 30.80M | 23.50M |
| Operating Income Ratio | 22.92% | 25.43% | 26.57% | 18.95% | 16.12% | 13.99% | 14.31% | 13.04% | 9.19% | 12.80% | 11.87% | 10.67% | 9.19% | 8.21% | 9.24% | 11.81% | 9.30% | 11.06% | 10.32% | 8.90% | 11.11% | 6.36% | 10.41% | 8.30% | 14.15% | 14.39% | 13.68% | 11.62% | 11.70% | 12.90% | 11.79% | 11.74% | -0.39% | 6.56% | 11.69% | 10.55% | 11.80% | 13.07% | 12.36% |
| Total Other Income/Expenses | 22.00M | -54.10M | -3.40M | -5.60M | -4.80M | 400.00K | -3.40M | -5.40M | -12.50M | -13.00M | -15.30M | -26.50M | -23.20M | -31.50M | -14.40M | -15.10M | -8.50M | -16.50M | -12.00M | -8.20M | -7.50M | -9.50M | -13.40M | -11.10M | -9.30M | -36.80M | -4.20M | -26.10M | -5.70M | -6.40M | -4.30M | -5.70M | -2.50M | -10.50M | -2.20M | -2.90M | -6.70M | -600.00K | 1.90M |
| Income Before Tax | 698.00M | 679.90M | 748.90M | 401.30M | 291.80M | 240.70M | 222.40M | 189.80M | 116.10M | 169.00M | 147.10M | 108.60M | 92.70M | 74.50M | 83.10M | 109.50M | 86.40M | 84.50M | 45.20M | 41.20M | 47.00M | 17.20M | 27.80M | 3.10M | 57.10M | 27.90M | 57.70M | 27.20M | 42.60M | 40.70M | 36.80M | 34.00M | -3.80M | 10.70M | 33.90M | 27.50M | 23.20M | 30.20M | 25.40M |
| Income Before Tax Ratio | 23.66% | 23.55% | 26.45% | 18.69% | 15.86% | 14.02% | 13.91% | 12.58% | 8.29% | 11.89% | 10.75% | 8.58% | 7.77% | 6.74% | 7.87% | 10.42% | 8.47% | 9.25% | 6.46% | 7.61% | 9.58% | 4.10% | 7.00% | 0.72% | 12.17% | 6.20% | 12.75% | 5.93% | 10.32% | 11.15% | 10.55% | 10.05% | -1.15% | 3.31% | 10.98% | 9.54% | 9.16% | 12.82% | 13.36% |
| Income Tax Expense | 122.30M | 114.70M | 107.20M | 72.50M | 59.00M | 41.40M | 80.90M | 54.40M | 26.30M | 47.20M | 40.20M | 32.70M | 23.50M | 13.60M | 13.50M | 23.70M | 17.20M | 24.60M | -400.00K | 11.10M | 16.70M | 4.10M | 8.60M | 1.50M | 18.40M | 21.20M | 13.30M | 10.80M | 13.90M | 13.40M | 14.30M | 14.30M | 4.70M | 6.40M | 13.20M | 10.10M | 9.50M | 13.20M | 10.40M |
| Net Income | 593.40M | 585.90M | 661.80M | 346.20M | 241.70M | 206.90M | 150.70M | 143.60M | 95.60M | 127.10M | 112.30M | 80.70M | 75.50M | 65.30M | 72.60M | 86.00M | 70.70M | 67.10M | 45.60M | 19.40M | 31.90M | 18.40M | -5.20M | 1.60M | 38.70M | 6.70M | 44.40M | 16.40M | 28.70M | 27.30M | 23.50M | 19.70M | -8.50M | 4.30M | 20.70M | 17.40M | 13.70M | 17.00M | 15.00M |
| Net Income Ratio | 20.12% | 20.30% | 23.37% | 16.13% | 13.14% | 12.05% | 9.42% | 9.52% | 6.83% | 8.94% | 8.21% | 6.37% | 6.33% | 5.91% | 6.88% | 8.18% | 6.93% | 7.35% | 6.52% | 3.58% | 6.50% | 4.38% | -1.31% | 0.37% | 8.25% | 1.49% | 9.81% | 3.57% | 6.95% | 7.48% | 6.74% | 5.82% | -2.58% | 1.33% | 6.71% | 6.04% | 5.41% | 7.22% | 7.89% |
| EPS | 7.99 | 7.88 | 8.90 | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 | 1.79 | 1.61 | 1.19 | 1.12 | 0.98 | 1.11 | 1.33 | 1.08 | 1.05 | 0.75 | 0.57 | 0.75 | 0.33 | -0.09 | 0.03 | 0.65 | 0.10 | 0.67 | 0.25 | 0.43 | 0.43 | 0.37 | 0.32 | -0.14 | 0.07 | 0.32 | 0.27 | 0.21 | 0.27 | 0.24 |
| EPS Diluted | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 | 1.30 | 1.75 | 1.57 | 1.15 | 1.08 | 0.95 | 1.06 | 1.25 | 1.02 | 1.00 | 0.71 | 0.56 | 0.75 | 0.33 | -0.09 | 0.03 | 0.64 | 0.10 | 0.67 | 0.25 | 0.43 | 0.43 | 0.37 | 0.31 | -0.14 | 0.07 | 0.32 | 0.27 | 0.21 | 0.27 | 0.24 |
| Weighted Avg Shares Out | 74.30M | 74.40M | 74.40M | 73.90M | 74.00M | 73.90M | 73.90M | 73.30M | 72.00M | 70.90M | 69.60M | 68.00M | 67.40M | 66.60M | 65.60M | 64.80M | 65.40M | 64.40M | 62.20M | 60.00M | 58.00M | 57.80M | 57.34M | 57.63M | 59.66M | 65.74M | 65.90M | 65.67M | 66.23M | 64.22M | 63.51M | 62.54M | 61.82M | 63.70M | 64.69M | 65.05M | 64.47M | 64.15M | 63.16M |
| Weighted Avg Shares Out (Dil) | 75.30M | 75.80M | 76.30M | 75.80M | 75.40M | 75.40M | 75.80M | 75.00M | 73.80M | 72.80M | 71.40M | 71.80M | 74.00M | 73.40M | 72.60M | 72.20M | 72.40M | 67.20M | 65.00M | 61.60M | 58.20M | 57.80M | 57.39M | 57.64M | 60.19M | 66.02M | 66.29M | 65.67M | 66.23M | 64.22M | 63.95M | 63.04M | 61.82M | 63.70M | 65.20M | 65.05M | 64.47M | 64.15M | 63.16M |
Medical equipment maker West Pharmaceutical raises 2023 profit forecast
Medical equipment maker West Pharmaceutical Services on Thursday raised its 2023 adjusted profit forecast for a third time, benefiting from a stronger dollar.
West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
EXTON, Pa. , Oct. 23, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Barcelona, Spain to showcase its leadership and expertise...
What's in Store for West Pharmaceutical (WST) in Q3 Earnings?
West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
7 Healthcare Stocks to invest in for a Healthy Future
One of my favorite sectors will always be the healthcare sector. It is practically a basic need for all human beings and is always in constant development and growth.
Analysts Estimate West Pharmaceutical Services (WST) to Report a Decline in Earnings: What to Look Out for
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
West Pharmaceutical Services: The Run Might Be Over
West Pharmaceutical Services, Inc. has experienced a 60% gain in its stock price so far in 2023 but has hit some recent technical headwinds. Insiders have also sold a significant number of shares in August and September, and the stock's...
West to Present on Development of Large Volume Delivery Systems, Self-injection Devices, and Prefillable Syringe Component Expertise at the PDA Conference
Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa. , Oct. 16, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration,...
West to Host Third-Quarter 2023 Conference Call
EXTON, Pa. , Oct. 12, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2023 financial results before the market opens on Thursday, October...
4 Stocks to Buy From the Prospering Dental Supplies Industry
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.
Source: https://incomestatements.info
Category: Stock Reports
What were West Pharmaceutical’s net sales in Q3 2024?
(NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024 dividend. Net sales of $746.9 million declined 0.1%; organic net sales decline was 0.5%. Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year.